Loading
RI
Relypsa Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by DONDERO JAMES D, was filed 18 Aug 2016.
Relypsa Inc: what insiders have been doing
This page follows insider dealings at Relypsa Inc as filed with SEC (Form 4). Nothing new has been filed by managers of Relypsa Inc in twelve months, the latest record being from 2 September 2016.
Since 2016, the database holds 3 purchases and 11 sales by insiders of the company.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
90
Thresholds
n/a
Buy Volume
€452,512
3 ops. · all time
Sell Volume
€119M
11 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2015FY ended December 2015 · cache
Income statement
Net income-US$154.7M
Last declaration on 2 September 2016
Declarations90 total
2,917 shares0Common StockSEC:0001140361-16-078621:0
4,167 shares0Common StockSEC:0001140361-16-078620:0
4,167 shares0Common StockSEC:0001140361-16-078619:0
11,250 shares0Common StockSEC:0001140361-16-078623:0
2,200 shares0Common StockSEC:0001140361-16-078622:0
2,917 shares0Common StockSEC:0001140361-16-078624:0
2,917 shares0Common StockSEC:0001140361-16-078618:0
4,167 shares0Common StockSEC:0001140361-16-078616:0
4,167 shares0Common StockSEC:0001140361-16-078617:0
2,495 shares@ US$32.0046.7% of flowCommon StockSEC:0001140361-16-078626:0
2,250 shares@ US$32.0042.1% of flowCommon StockSEC:0001140361-16-078626:1
1,237 shares@ US$32.0030.2% of flowCommon StockSEC:0001140361-16-078627:0
2,250 shares@ US$32.0055.0% of flowCommon StockSEC:0001140361-16-078627:1
1,237 shares@ US$32.0030.2% of flowCommon StockSEC:0001140361-16-078631:0
2,250 shares@ US$32.0055.0% of flowCommon StockSEC:0001140361-16-078631:1
1,237 shares@ US$32.0030.2% of flowCommon StockSEC:0001140361-16-078630:0
2,250 shares@ US$32.0055.0% of flowCommon StockSEC:0001140361-16-078630:1
3,479 shares@ US$32.0018.3% of flowCommon StockSEC:0001140361-16-078621:1
14,167 shares@ US$32.0074.5% of flowCommon StockSEC:0001140361-16-078621:2
2,849 shares@ US$32.0050.0% of flowCommon StockSEC:0001140361-16-078625:0
2,250 shares@ US$32.0039.5% of flowCommon StockSEC:0001140361-16-078625:1
5,969 shares@ US$32.0024.9% of flowCommon StockSEC:0001140361-16-078620:1
16,042 shares@ US$32.0066.8% of flowCommon StockSEC:0001140361-16-078620:2
33,962 shares@ US$32.0069.5% of flowCommon StockSEC:0001140361-16-078629:0
2,250 shares@ US$32.004.6% of flowCommon StockSEC:0001140361-16-078629:1
25 of 90 declarations
About Relypsa Inc
Relypsa Inc is a biopharmaceutical company focused on developing treatments for kidney diseases. It is listed on NASDAQ under the ticker RLYP.
